Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Roger Nation (1) , Jian Li (2) , Otto Cars (3) , William Couet (4, 5, 6) , Michael Dudley , Keith Kaye (7) , Johan Mouton (8) , David Paterson (9) , Vincent Tam (10) , Ursula Theuretzbacher (11) , Brian Tsuji (12) , John Turnidge (13)

1 Monash University [Melbourne]
2 School of Computer Science and Technology, Harbin Institute of Technology
3 Uppsala University
4 PHAR [Poitiers] - Pharmacologie des anti-infectieux
5 CHU de Poitiers [La Milétrie] - Centre hospitalier universitaire de Poitiers = Poitiers University Hospital
6 Université de Poitiers - Faculté de Médecine et de Pharmacie
7 Wayne State University [Detroit]
8 Erasmus University Medical Centre Rotterdam
9 Australian Synchrotron [Clayton]
10 University of Houston
11 Center for Anti-Infective Agents
12 SUNY Buffalo - University at Buffalo [SUNY]
13 University of Adelaide

Domaines: Sciences du Vivant [q-bio]; Sciences pharmaceutiques

Roger Nation, Jian Li, Otto Cars, William Couet, Michael Dudley, et al.. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. The Lancet Infectious Diseases, 2015, 15 (2), pp.225-234. ⟨10.1016/S1473-3099(14)70850-3⟩. ⟨hal-02479001⟩